z-logo
open-access-imgOpen Access
Breakthrough-Therapy Designation — An FDA Perspective
Author(s) -
Jacqueline CorriganCuray,
Amy E. McKee,
Peter Stein
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmc1801222
Subject(s) - medicine , food and drug administration , perspective (graphical) , intensive care medicine , drug approval , pharmacology , drug , artificial intelligence , computer science

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom